Skip to main contentAll experts

Sarah Kim

AST PROF

PH-PHARMACEUTICS

Orcid identifier0000-0002-9179-0735 (opens in a new tab)⁠
  • AST PROF
    PH-PHARMACEUTICS

GRANTS

  • GRANT
    Disease Progression Models Intended to Inform the Design of Studies for LGMD
    Critical Path Institute6 Apr 2026 - 31 Mar 2028
    Active
  • GRANT
    Harnessing Explainable AI to Unravel Interindividual Differences in Disease Progression and Response to Therapeutic Interventions in Parkinson's Patients
    Takeda Development Center Americas Inc6 Nov 2025 - 15 Oct 2027
    Active
  • GRANT
    2026 Darrell Abernethy Early Stage Investigator Award
    American Society for Clinical Pharmacology & Thera17 Sep 2025 - 31 Dec 2026
    Active
  • GRANT
    Model-Informed Clinical Trial Design for Duchenne Muscular Dystrophy: Modeling Treatment Effects and Enhancing Simulation Tools
    Parent Project Muscular Dystrophy12 Aug 2025 - 30 Sep 2027
    Active
  • GRANT
    Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression
    National Institute of Health Niaid25 Jan 2023 - 31 Dec 2027
    Active
  • GRANT
    Quantifying Clinical and Genetic Factors Influencing Rate and Severity of Mucin1 (MUC1) and Uromodulin (UMOD) Variants of Autosomal Dominant Tubulointerstitial Kidney Disease
    Sail Bio23 Aug 2022 - 31 Jul 2025
    Expired
  • GRANT
    Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression
    Breakthrough T1d - Formerly Jdrf International2 May 2022 - 31 May 2026
    Expired
  • GRANT
    Optimizing Muscular Dystrophy Clinical Trial Designs using Modeling and Simulation
    National Institute of Health Ncats16 Aug 2021 - 31 Jul 2024
    Expired
  • GRANT
    A Model-based Clinical Trial Simulation Tool to Optimize Clinical Trial Designs for Type 1 Diabetes Prevention Studies
    Breakthrough T1d - Formerly Jdrf International16 Jan 2020 - 31 Jan 2023
    Expired
  • GRANT
    A Model-based Clinical Trial Simulation Tool to Optimize Clinical Trial Design of Studies to Investigate Efficacy of Potential Therapies for Duchenne Muscular Dystrophy
    Critical Path Institute7 Mar 2019 - 6 Mar 2020
    Expired